Orexo Enters Research Agreement with AstraZeneca for Respiratory Disease Program.Under this agreement, Orexo grants to AstraZeneca rights to conduct further preclinical research and evaluation of compounds in Orexo’s OX-CLI program.
URL:
www.businesswire.com/news/home/20130124006646/en/Orexo-Enters-Research-Agreement-AstraZeneca-Respiratory-Disease
No comments:
Post a Comment